UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations

Cannabidiol (CBD) is a promising therapeutic agent with analgesic, myorelaxant, and anti-epileptic actions. Recently, a purified form of CBD (Epidiolex<sup>®</sup>) has been approved by the European Medicines Agency (EMA) for the treatment of two highly-refractory childhood-onset epileps...

Full description

Saved in:
Bibliographic Details
Main Authors: Sara Malaca (Author), Massimo Gottardi (Author), Federica Pigliasco (Author), Sebastiano Barco (Author), Alessia Cafaro (Author), Elisabetta Amadori (Author), Antonella Riva (Author), Martina Marcenaro (Author), Pasquale Striano (Author), Giuliana Cangemi (Author), Roberta Pacifici (Author), Simona Pichini (Author), Francesco Paolo Busardò (Author)
Format: Book
Published: MDPI AG, 2021-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available